应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02315 百奥赛图-B
休市中 04-19 16:08:35
7.400
+0.280
+3.93%
最高
7.640
最低
6.800
成交量
14.35万
今开
7.160
昨收
7.120
日振幅
11.80%
总市值
29.56亿
流通市值
8.20亿
总股本
3.99亿
成交额
103.19万
换手率
0.13%
流通股本
1.11亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
百奥赛图-B盘中异动 下午盘股价大涨5.20%
自选股智能写手 · 04-19 13:54
百奥赛图-B盘中异动 下午盘股价大涨5.20%
百奥赛图-B(02315)股价上升5.197%,现价港币$7.49
阿斯达克财经 · 04-19 13:54
百奥赛图-B(02315)股价上升5.197%,现价港币$7.49
百奥赛图-B盘中异动 临近收盘股价大涨5.19%
自选股智能写手 · 04-18 15:30
百奥赛图-B盘中异动 临近收盘股价大涨5.19%
百奥赛图-B盘中异动 急速上涨5.11%报7.000港元
自选股智能写手 · 04-16
百奥赛图-B盘中异动 急速上涨5.11%报7.000港元
百奥赛图-B(02315)上涨12.09%,报6.86元/股
金融界 · 04-12
百奥赛图-B(02315)上涨12.09%,报6.86元/股
百奥赛图-B(02315)股价上升9.804%,现价港币$6.72
阿斯达克财经 · 04-12
百奥赛图-B(02315)股价上升9.804%,现价港币$6.72
百奥赛图-B(02315.HK):生产经营活动未发生任何重大不利事项 料今年近盈亏平衡
阿斯达克财经 · 04-12
百奥赛图-B(02315.HK):生产经营活动未发生任何重大不利事项 料今年近盈亏平衡
百奥赛图-B稳步增长 2024年盈亏平衡预期 斥资4000万港币购股
和讯网 · 04-12
百奥赛图-B稳步增长 2024年盈亏平衡预期 斥资4000万港币购股
百奥赛图-B(02315):各业务线均保持稳健增长且按照既定战略稳步推进 拟不超1000万港元进行进一步股份购买
智通财经 · 04-11
百奥赛图-B(02315):各业务线均保持稳健增长且按照既定战略稳步推进 拟不超1000万港元进行进一步股份购买
百奥赛图-B(02315.HK)有望于2024年接近盈亏平衡点 拟不超1000万港币进行进一步股份购买
格隆汇资讯 · 04-11
百奥赛图-B(02315.HK)有望于2024年接近盈亏平衡点 拟不超1000万港币进行进一步股份购买
百奥赛图-B盘中异动 大幅下挫5.09%
自选股智能写手 · 04-11
百奥赛图-B盘中异动 大幅下挫5.09%
百奥赛图-B(02315)下跌5.31%,报6.06元/股
金融界 · 04-10
百奥赛图-B(02315)下跌5.31%,报6.06元/股
百奥赛图-B盘中异动 股价大跌5.01%
自选股智能写手 · 04-10
百奥赛图-B盘中异动 股价大跌5.01%
百奥赛图-B(02315)下跌5.94%,报6.49元/股
金融界 · 04-09
百奥赛图-B(02315)下跌5.94%,报6.49元/股
百奥赛图-B盘中异动 急速跳水5.23%报6.540港元
自选股智能写手 · 04-09
百奥赛图-B盘中异动 急速跳水5.23%报6.540港元
百奥赛图-B盘中异动 快速下挫6.08%
自选股智能写手 · 04-05
百奥赛图-B盘中异动 快速下挫6.08%
百奥赛图-B(02315)下跌5.09%,报8.21元/股
金融界 · 04-02
百奥赛图-B(02315)下跌5.09%,报8.21元/股
百奥赛图-B盘中异动 股价大跌5.09%
自选股智能写手 · 04-02
百奥赛图-B盘中异动 股价大跌5.09%
一图看懂百奥赛图-B(02315.HK)2023年度业绩
格隆汇资讯 · 03-27
一图看懂百奥赛图-B(02315.HK)2023年度业绩
加载更多
公司概况
公司名称:
百奥赛图-B
所属市场:
SEHK
上市日期:
--
主营业务:
北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。该公司运营两个业务部门。药物开发业务部门主要从事肿瘤学和自身免疫性疾病治疗的研发,及抗体开发业务。临床前研究服务部门主要从事基因编辑、临床前药理药效评估及模式动物销售。
发行价格:
--
{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":7.4,"timestamp":1713514115031,"preClose":7.12,"halted":0,"volume":143500,"delay":0,"floatShares":110781920,"shares":399398420,"eps":-1.038259,"marketStatus":"休市中","marketStatusCode":7,"change":0.28,"latestTime":"04-19 16:08:35","open":7.16,"high":7.64,"low":6.8,"amount":1031885,"amplitude":0.117978,"askPrice":7.65,"askSize":1000,"bidPrice":7.32,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-1.038258990727543,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"listingDate":1661961600000,"adjPreClose":7.12,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0.9735413832626219,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02315/","defaultTab":"news","newsList":[{"id":"2428500181","title":"百奥赛图-B盘中异动 下午盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428500181","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428500181?lang=zh_cn&edition=full","pubTime":"2024-04-19 13:54","pubTimestamp":1713506096,"startTime":"0","endTime":"0","summary":"2024年04月19日下午盘13时54分,百奥赛图-B股票出现异动,股价大幅拉升5.20%。百奥赛图-B股票所在的生物技术行业中,整体跌幅为1.17%。其相关个股中,创胜集团-B、百奥赛图-B、帝王国际投资涨幅较大,振幅较大的相关个股有乐普生物-B、三叶草生物-B、创胜集团-B,振幅分别为13.02%、12.70%、12.50%。百奥赛图-B公司简介:北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041913545687e8211e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041913545687e8211e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428568864","title":"百奥赛图-B(02315)股价上升5.197%,现价港币$7.49","url":"https://stock-news.laohu8.com/highlight/detail?id=2428568864","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428568864?lang=zh_cn&edition=full","pubTime":"2024-04-19 13:54","pubTimestamp":1713506040,"startTime":"0","endTime":"0","summary":"[上升股]百奥赛图-B(02315) 股价在下午01:54比前收市价上升5.197%,现股价为港币$7.49。至目前为止,今日最高价为$7.49,而最低价为$6.8。总成交量为8.75万股,总成交金额为港币$61.458万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404192009/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428555488","title":"百奥赛图-B盘中异动 临近收盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428555488","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428555488?lang=zh_cn&edition=full","pubTime":"2024-04-18 15:30","pubTimestamp":1713425458,"startTime":"0","endTime":"0","summary":"2024年04月18日临近收盘15时30分,百奥赛图-B股票出现波动,股价快速拉升5.19%。百奥赛图-B股票所在的生物技术行业中,整体跌幅为0.23%。其相关个股中,百奥赛图-B、加科思-B、创胜集团-B涨幅较大,振幅较大的相关个股有创胜集团-B、奥星生命科技、圣诺医药-B,振幅分别为17.42%、11.65%、11.27%。百奥赛图-B公司简介:北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181530587a53aac5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181530587a53aac5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427894847","title":"百奥赛图-B盘中异动 急速上涨5.11%报7.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427894847","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427894847?lang=zh_cn&edition=full","pubTime":"2024-04-16 13:32","pubTimestamp":1713245542,"startTime":"0","endTime":"0","summary":"2024年04月16日下午盘13时32分,百奥赛图-B股票出现异动,股价急速上涨5.11%。截至发稿,该股报7.000港元/股,成交量8.6万股,换手率0.08%,振幅5.86%。百奥赛图-B股票所在的生物技术行业中,整体跌幅为0.91%。其相关个股中,创胜集团-B、百奥赛图-B、维亚生物涨幅较大,振幅较大的相关个股有来凯医药-B、圣诺医药-B、乐普生物-B,振幅分别为23.65%、13.98%、13.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416133223861e62f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416133223861e62f2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426272860","title":"百奥赛图-B(02315)上涨12.09%,报6.86元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426272860","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426272860?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:47","pubTimestamp":1712908059,"startTime":"0","endTime":"0","summary":"4月12日,百奥赛图-B(02315)盘中上涨12.09%,截至15:47,报6.86元/股,成交100.71万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司,拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台,已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发,已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2023年年报,百奥赛图-B营业总收入7.17亿元、净利润-3.83亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/12154740216458.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426422608","title":"百奥赛图-B(02315)股价上升9.804%,现价港币$6.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2426422608","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426422608?lang=zh_cn&edition=full","pubTime":"2024-04-12 11:50","pubTimestamp":1712893800,"startTime":"0","endTime":"0","summary":"[上升股]百奥赛图-B(02315) 股价在上午11:50比前收市价上升9.804%,现股价为港币$6.72。至目前为止,今日最高价为$6.72,而最低价为$6.2。总成交量为8.4万股,总成交金额为港币$54.865万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404122226/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426373245","title":"百奥赛图-B(02315.HK):生产经营活动未发生任何重大不利事项 料今年近盈亏平衡","url":"https://stock-news.laohu8.com/highlight/detail?id=2426373245","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426373245?lang=zh_cn&edition=full","pubTime":"2024-04-12 08:48","pubTimestamp":1712882880,"startTime":"0","endTime":"0","summary":"百奥赛图-B公布,注意到其在联交所上市的股份股价近期出现不寻常波动,其生产经营活动未发生任何重大不利事项,各业务线均保持稳健增长且按照既定战略稳步推进。董事会及管理团队对公司发展前景充满信心,预期生产经营活动以及财务状况不会出现任何重大不利变动。公司测算有望于今年接近盈亏平衡点。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20221007162259565_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20221007162259565_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1341757/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2426176792","title":"百奥赛图-B稳步增长 2024年盈亏平衡预期 斥资4000万港币购股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426176792","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2426176792?lang=zh_cn&edition=full","pubTime":"2024-04-12 00:44","pubTimestamp":1712853855,"startTime":"0","endTime":"0","summary":"公司股价近期出现不寻常波动,但生产经营活动未发生任何重大不利事项。公司有望于2024年接近盈亏平衡点,这是根据2024年1月5日海外监管公告中披露的谨慎测算。2022年与2023年,公司通过招商永隆信托有限公司管理股份奖励计划,购买公司H股。截至2023年底,公司通过自有闲置资金进行股份购买的总对价约为3000万港币。公司拟以不超过1000万港币的资金进行进一步股份购买,以支持未来计划的实施。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412073415876ac668&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412073415876ac668&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426540502","title":"百奥赛图-B(02315):各业务线均保持稳健增长且按照既定战略稳步推进 拟不超1000万港元进行进一步股份购买","url":"https://stock-news.laohu8.com/highlight/detail?id=2426540502","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426540502?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:00","pubTimestamp":1712840457,"startTime":"0","endTime":"0","summary":"公司谨此说明,其生产经营活动未发生任何重大不利事项,各业务线均保持稳健增长且按照既定战略稳步推进。截至2023年底,通过公司自有闲置资金进行股份购买的总对价约为3000万港币。由于董事会认为公司股份目前价值被严重低估,故现在为对股份奖励计划的相关股份进行增补的适当时机,公司拟以不超过1000万港币的资金进行进一步股份购买。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1101369.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426254528","title":"百奥赛图-B(02315.HK)有望于2024年接近盈亏平衡点 拟不超1000万港币进行进一步股份购买","url":"https://stock-news.laohu8.com/highlight/detail?id=2426254528","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2426254528?lang=zh_cn&edition=full","pubTime":"2024-04-11 20:45","pubTimestamp":1712839541,"startTime":"0","endTime":"0","summary":"格隆汇4月11日丨百奥赛图-B公告,公司注意到公司在香港联合交易所有限公司上市的股份的股价近期出现不寻常波动。如2024年1月5日海外监管公告中披露,经公司谨慎测算,公司有望于2024年接近盈亏平衡点。截至2023年底,通过公司自有闲置资金进行股份购买的总对价约为3,000万港币。由于董事会认为公司股份目前价值被严重低估,故现在为对股份奖励计划的相关股份进行增补的适当时机,公司拟以不超过1,000万港币的资金进行进一步股份购买。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112045498b105a67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112045498b105a67&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426409827","title":"百奥赛图-B盘中异动 大幅下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426409827","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426409827?lang=zh_cn&edition=full","pubTime":"2024-04-11 11:48","pubTimestamp":1712807297,"startTime":"0","endTime":"0","summary":"2024年04月11日临近午盘11时48分,百奥赛图-B股票出现异动,股价快速跳水5.09%。截至发稿,该股报5.800港元/股,成交量12万股,换手率0.11%,振幅4.09%。机构评级方面,在所有2家参与评级的机构中,50%的券商给予买入建议,50%的券商给予卖出建议,无券商给予持有建议。百奥赛图-B股票所在的生物技术行业中,整体跌幅为1.32%。百奥赛图-B公司简介:北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041111481787e7f8d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041111481787e7f8d2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426438596","title":"百奥赛图-B(02315)下跌5.31%,报6.06元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426438596","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426438596?lang=zh_cn&edition=full","pubTime":"2024-04-10 13:39","pubTimestamp":1712727553,"startTime":"0","endTime":"0","summary":"4月10日,百奥赛图-B(02315)盘中下跌5.31%,截至13:39,报6.06元/股,成交100.82万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司,拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台,已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发,已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2023年年报,百奥赛图-B营业总收入7.17亿元、净利润-3.83亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/10133940178908.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426868854","title":"百奥赛图-B盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426868854","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426868854?lang=zh_cn&edition=full","pubTime":"2024-04-10 11:26","pubTimestamp":1712719578,"startTime":"0","endTime":"0","summary":"2024年04月10日早盘11时26分,百奥赛图-B股票出现波动,股价快速下跌5.01%。截至发稿,该股报6.080港元/股,成交量10.85万股,换手率0.10%,振幅4.53%。百奥赛图-B股票所在的生物技术行业中,整体涨幅为0.34%。百奥赛图-B公司简介:北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101126187a51c7d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101126187a51c7d1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426750138","title":"百奥赛图-B(02315)下跌5.94%,报6.49元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426750138","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426750138?lang=zh_cn&edition=full","pubTime":"2024-04-09 13:23","pubTimestamp":1712640228,"startTime":"0","endTime":"0","summary":"4月9日,百奥赛图-B(02315)盘中下跌5.94%,截至13:23,报6.49元/股,成交100.3万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司,拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台,已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发,已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2023年年报,百奥赛图-B营业总收入7.17亿元、净利润-3.83亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/09132340161982.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426110901","title":"百奥赛图-B盘中异动 急速跳水5.23%报6.540港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426110901","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426110901?lang=zh_cn&edition=full","pubTime":"2024-04-09 09:47","pubTimestamp":1712627279,"startTime":"0","endTime":"0","summary":"2024年04月09日早盘09时47分,百奥赛图-B股票出现波动,股价急速跳水5.23%。截至发稿,该股报6.540港元/股,成交量1.55万股,换手率0.01%,振幅5.94%。资金方面,该股资金流入3.3775万港元,流出7.11万港元。百奥赛图-B股票所在的生物技术行业中,整体涨幅为0.26%。百奥赛图-B公司简介:北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090947597a5181b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090947597a5181b0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425305293","title":"百奥赛图-B盘中异动 快速下挫6.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425305293","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425305293?lang=zh_cn&edition=full","pubTime":"2024-04-05 10:27","pubTimestamp":1712284076,"startTime":"0","endTime":"0","summary":"2024年04月05日早盘10时27分,百奥赛图-B股票出现波动,股价急速下跌6.08%。截至发稿,该股报7.401港元/股,成交量1.55万股,换手率0.01%,振幅6.09%。百奥赛图-B股票所在的生物技术行业中,整体跌幅为1.30%。百奥赛图-B公司简介:北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405102756791ed3ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405102756791ed3ca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424068171","title":"百奥赛图-B(02315)下跌5.09%,报8.21元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424068171","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424068171?lang=zh_cn&edition=full","pubTime":"2024-04-02 15:10","pubTimestamp":1712041832,"startTime":"0","endTime":"0","summary":"4月2日,百奥赛图-B(02315)盘中下跌5.09%,截至15:10,报8.21元/股,成交107.12万元。百奥赛图(北京)医药科技股份有限公司是一家以创新技术驱动新药研发为主营业务的生物技术公司,拥有自主研发并拥有完全独立知识产权的全人抗体RenMiceTM平台,已建立起12项核心药物产品管线。公司正在对1000多个潜在可成药的靶点进行规模化药物开发,已签署了24项药物合作开发协议并与14家企业达成RenMice平台授权合作。截至2023年年报,百奥赛图-B营业总收入7.17亿元、净利润-3.83亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/02151040092387.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424068844","title":"百奥赛图-B盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424068844","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424068844?lang=zh_cn&edition=full","pubTime":"2024-04-02 15:10","pubTimestamp":1712041829,"startTime":"0","endTime":"0","summary":"2024年04月02日下午盘15时10分,百奥赛图-B股票出现异动,股价大幅下挫5.09%。资金方面,该股资金流入52.428万港元,流出50.918万港元。百奥赛图-B股票所在的生物技术行业中,整体跌幅为0.33%。百奥赛图-B公司简介:北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404021510307a509bcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404021510307a509bcc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422698129","title":"一图看懂百奥赛图-B(02315.HK)2023年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2422698129","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2422698129?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:20","pubTimestamp":1711534808,"startTime":"0","endTime":"0","summary":"3月26日晚间,百奥赛图-B(02315.HK)发布截至2023年12月31日止年度业绩,2023年度,集团实现营收达人民币7.17亿元(单位下同),同比增长34%,其中海外营收达4.08亿元,同比增长66%,毛利率71%,基本稳定在较高水平。下面将通过一图看懂百奥赛图-B(02315.HK)2023年度业绩。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271820528b69548b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271820528b69548b&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":0.1212},{"period":"1month","weight":-0.2178},{"period":"3month","weight":-0.26},{"period":"6month","weight":-0.3357},{"period":"1year","weight":-0.701},{"period":"ytd","weight":-0.3823}],"compareEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0193},{"period":"3month","weight":0.0598},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.2046},{"period":"ytd","weight":-0.0483}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京百奥赛图基因生物技术有限公司是一家主要从事药物开发业务及临床前研究中国公司。该公司运营两个业务部门。药物开发业务部门主要从事肿瘤学和自身免疫性疾病治疗的研发,及抗体开发业务。临床前研究服务部门主要从事基因编辑、临床前药理药效评估及模式动物销售。","exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}